Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis

Purpose: Calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) are new agents approved by the US Food and Drug Administration for preventive treatment of chronic migraine. Comparison between CGRPmAbs and previously approved Botulinum neurotoxin A (BoNT-A) will inform optimal preventive tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yao-Yao, Ye, Xiao-Qian, Tang, Tai-Chun, She, Tian-Wei, Chen, Min, Zheng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170150/
https://www.ncbi.nlm.nih.gov/pubmed/34093199
http://dx.doi.org/10.3389/fphar.2021.671845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170150/
https://www.ncbi.nlm.nih.gov/pubmed/34093199
http://dx.doi.org/10.3389/fphar.2021.671845

Ejemplares similares